Brain-computer interface company Synchron announced its receipt of an oversubscribed $75 million Series C funding round, bringing its total raise to $145 million.
ARCH Venture Partners led the round with additional investment from Bezos Expeditions, Greenoaks, Alumni Ventures, Moore Strategic Ventures, Gates Frontier, Project X and Reliance Digital Health Limited.
The company's board of directors...
Synchron, the startup behind an FDA breakthrough neuroprosthesis device that aims to give patients with paralysis the ability to control digital devices with their thoughts, has been cleared by the FDA to begin a clinical trial with human participants.
Called the COMMAND trial, the study will take place later this year at Mount Sinai Hospital in New York and will include six patients with severe...
Consumer genomics company Helix landed $50 million in a Series C funding round led by Warburg Pincus, DFJ Growth, Kleiner Perkins Caufield Byers, Mayo Clinic and Temasek.
Helix is able to analyze customers' DNA and give them insights into their health and heritage, based on the user request. Users submit one sample of DNA, which the company stores and is able to pull when the client requests...
